These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9786445)

  • 1. Selective serotonin re-uptake inhibitors for the treatment of perseverative and maladaptive behaviours of people with intellectual disability.
    Branford D; Bhaumik S; Naik B
    J Intellect Disabil Res; 1998 Aug; 42 ( Pt 4)():301-6. PubMed ID: 9786445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
    Moore ML; Eichner SF; Jones JR
    Ann Pharmacother; 2004 Sep; 38(9):1515-9. PubMed ID: 15292500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic antidepressant effects on aggressive, self-injurious and destructive/disruptive behaviours in intellectually disabled adults: a retrospective, open-label, naturalistic trial.
    Janowsky DS; Shetty M; Barnhill J; Elamir B; Davis JM
    Int J Neuropsychopharmacol; 2005 Mar; 8(1):37-48. PubMed ID: 15482629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
    Strawn JR; Mills JA; Croarkin PE
    J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of serotonin re-uptake inhibitors with perhexiline.
    Alderman CP; Hundertmark JD; Soetratma TW
    Aust N Z J Psychiatry; 1997 Aug; 31(4):601-3. PubMed ID: 9272272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxetine treatment of aggression and self-injury in persons with mental retardation.
    Davanzo PA; Belin TR; Widawski MH; King BH
    Am J Ment Retard; 1998 Mar; 102(5):427-37. PubMed ID: 9544340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressants and the risk of suicidal behaviors.
    Jick H; Kaye JA; Jick SS
    JAMA; 2004 Jul; 292(3):338-43. PubMed ID: 15265848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relief of SSRI-induced sexual dysfunction with mirtazapine treatment.
    Farah A
    J Clin Psychiatry; 1999 Apr; 60(4):260-1. PubMed ID: 10221289
    [No Abstract]   [Full Text] [Related]  

  • 9. Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment.
    Judge R; Parry MG; Quail D; Jacobson JG
    Int Clin Psychopharmacol; 2002 Sep; 17(5):217-25. PubMed ID: 12177584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
    Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial.
    Kroenke K; West SL; Swindle R; Gilsenan A; Eckert GJ; Dolor R; Stang P; Zhou XH; Hays R; Weinberger M
    JAMA; 2001 Dec; 286(23):2947-55. PubMed ID: 11743835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.
    Fava M; Judge R; Hoog SL; Nilsson ME; Koke SC
    J Clin Psychiatry; 2000 Nov; 61(11):863-7. PubMed ID: 11105740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin reuptake inhibitor-related extrapyramidal side effects in two patients with cerebral palsy.
    Rone LA; Ferrando SJ
    Psychosomatics; 1996; 37(2):165-6. PubMed ID: 8742546
    [No Abstract]   [Full Text] [Related]  

  • 14. Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects.
    Kennedy SH; McCann SM; Masellis M; McIntyre RS; Raskin J; McKay G; Baker GB
    J Clin Psychiatry; 2002 Mar; 63(3):181-6. PubMed ID: 11926715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
    Diav-Citrin O; Shechtman S; Weinbaum D; Wajnberg R; Avgil M; Di Gianantonio E; Clementi M; Weber-Schoendorfer C; Schaefer C; Ornoy A
    Br J Clin Pharmacol; 2008 Nov; 66(5):695-705. PubMed ID: 18754846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation.
    Bogetto F; Bellino S; Revello RB; Patria L
    CNS Drugs; 2002; 16(4):273-83. PubMed ID: 11945110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of SNS activation on SSRI-induced sexual side effects differ by SSRI.
    Ahrold TK; Meston CM
    J Sex Marital Ther; 2009; 35(4):311-9. PubMed ID: 19466669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of kleptomania with serotonin reuptake inhibitors.
    Lepkifker E; Dannon PN; Ziv R; Iancu I; Horesh N; Kotler M
    Clin Neuropharmacol; 1999; 22(1):40-3. PubMed ID: 10047933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
    Preskorn S
    Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():13-9. PubMed ID: 7963446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents.
    Garland EJ; Baerg EA
    J Child Adolesc Psychopharmacol; 2001; 11(2):181-6. PubMed ID: 11436958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.